Malu Lian Hestdalen

  • Consultant; MD
 

Publications 2026

Suul SG, Kvam AK, Hestdalen ML, Randen U, Midtvedt Ø, Tjønnfjord GE (2026)
Cryoglobulinemia Type II: Sustained Remission After B-Cell-Directed Therapy
Am J Case Rep, 27, e950857
DOI 10.12659/AJCR.950857, PubMed 41792990

Publications 2025

Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I (2025)
Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera
Cancer Genomics Proteomics, 22 (1), 24-33
DOI 10.21873/cgp.20483, PubMed 39730178

Publications 2022

Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660

Scroll to top